5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis

5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis

Bibliographic Details
Main Authors:	Didier, Alain, Horak, Friedrich, Worm, Margitta, Malling, Hans-Jorgen, Montagut, Armelle, Rodriguez, Patricia, Zeldin, Robert K., Lheritier-Barrand, Michèle
Format:	Online
Language:	English
Published:	World Allergy Organization Journal 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512850/

Similar Items

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
by: Cox, Linda, et al.
Published: (2012)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
by: Malling, H-J, et al.
Published: (2009)

Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
by: Didier, Alain, et al.
Published: (2015)

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
by: Worm, Margitta, et al.
Published: (2014)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
by: Demoly, Pascal, et al.
Published: (2015)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
by: Karagiannis, Efstrathios, et al.
Published: (2014)

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
by: Horak, F, et al.
Published: (2009)

A major step forward for sublingual immunotherapy: the quality of 5-grass pollen tablet is recognized also in Italy
by: Ciprandi, Giorgio
Published: (2015)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
by: Hebert, Jacques, et al.
Published: (2011)

A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
by: Alesina, Roberta, et al.
Published: (2012)

Exposure to grass pollen – but not birch pollen – affects lung function in Swedish children
by: Gruzieva, O., et al.
Published: (2015)

Evaluation of the frequency and severity of seasonal allergic rhinoconjunctivitis caused by grass pollen in children with hazelnut sensitization
by: Cavkaytar, O, et al.
Published: (2013)

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
by: Rønborg, Steen M, et al.
Published: (2012)

488 The Effect of Specific Immunotherapy on the Clinical Response in Patients with Grass-pollen Induced Rhinoconjunctivitis
by: Arsovski, Zoran, et al.
Published: (2012)

Sensitization to timothy grass pollen allergenic molecules in children
by: Scaparrotta, Alessandra, et al.
Published: (2013)

Sensitization to cereals and peanut evidenced by skin prick test and specific IgE in food-tolerant, grass pollen allergic patients
by: Martens, Maria, et al.
Published: (2011)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
by: Bryson, Rebecca
Published: (2012)

Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
by: Marcucci, Francesco, et al.
Published: (2012)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
by: Pfaar, Oliver, et al.
Published: (2015)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
by: Devillier, Philippe, et al.
Published: (2014)

Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
by: Poole, Chris D, et al.
Published: (2014)

Mass spectrometric analysis of electrophoretically separated allergens and proteases in grass pollen diffusates
by: Raftery, Mark J, et al.
Published: (2003)

Subtropical grass pollen allergens are important for allergic respiratory diseases in subtropical regions
by: Davies, Janet Mary, et al.
Published: (2012)

12 Comprehensive Detection of Allergens in Grass Pollen Extracts by Mass Spectrometry
by: Augustin, Steffen, et al.
Published: (2012)

Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients
by: Moreira, Priscila Ferreira de Sousa, et al.
Published: (2015)

Critical appraisal of Timothy grass pollen extract GRAZAX® in the management of allergic rhinitis
by: Scaparrotta, Alessandra, et al.
Published: (2015)

Efficiacy of injection specific immunotherapy for grass pollen seasonal allergic rhinitis
by: Wasilewska, Eliza, et al.
Published: (2015)

Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU)
by: Ellis, Anne K, et al.
Published: (2015)

Threat of allergenic airborne grass pollen in Szczecin, NW Poland: the dynamics of pollen seasons, effect of meteorological variables and air pollution
by: Puc, Małgorzata
Published: (2010)

A Group-1 Grass Pollen Allergen Influences the Outcome of Pollen Competition in Maize
by: Valdivia, Elene R., et al.
Published: (2007)

Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis
by: Kiotseridis, Hampus, et al.
Published: (2013)

Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults
by: Ruggeri, Matteo, et al.
Published: (2013)

Atopic donor status does not influence the uptake of the major grass pollen allergen, Phl p 5, by dendritic cells
by: Ashjaei, Kazem, et al.
Published: (2015)

Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy
by: Savi, Eleonora, et al.
Published: (2013)

Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5
by: Levin, M, et al.
Published: (2014)

Induction of Eosinophilic Esophagitis by Sublingual Pollen Immunotherapy
by: Miehlke, Stephan, et al.
Published: (2013)

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
by: Zieglmayer, Petra, et al.
Published: (2016)

Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
by: Nembrini, Chiara, et al.
Published: (2015)

2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test
by: Sager, Angelika, et al.
Published: (2012)

5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study
by: Pastorello, Elide Anna, et al.
Published: (2013)